These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. In vivo 7Li nuclear magnetic resonance study of lithium pharmacokinetics and chemical shift imaging in psychiatric patients. Komoroski RA; Newton JE; Sprigg JR; Cardwell D; Mohanakrishnan P; Karson CN Psychiatry Res; 1993 Jun; 50(2):67-76. PubMed ID: 8378489 [TBL] [Abstract][Full Text] [Related]
24. Detecting psychoactive drugs in the developmental stages of mushrooms. Gross ST J Forensic Sci; 2000 May; 45(3):527-37. PubMed ID: 10855955 [TBL] [Abstract][Full Text] [Related]
25. Return of the lysergamides. Part III: Analytical characterization of N Brandt SD; Kavanagh PV; Westphal F; Elliott SP; Wallach J; Stratford A; Nichols DE; Halberstadt AL Drug Test Anal; 2017 Oct; 9(10):1641-1649. PubMed ID: 28342178 [TBL] [Abstract][Full Text] [Related]
26. More data about the new psychoactive drug 2C-B. de Boer D; Gijzels MJ; Bosman IJ; Maes RA J Anal Toxicol; 1999; 23(3):227-8. PubMed ID: 10369336 [No Abstract] [Full Text] [Related]
27. Drug checking to improve monitoring of new psychoactive substances in Australia. Butterfield RJ; Barratt MJ; Ezard N; Day RO Med J Aust; 2016 Mar; 204(4):144-5. PubMed ID: 26937663 [No Abstract] [Full Text] [Related]
28. The use of presumptive color tests for new psychoactive substances. Cuypers E; Bonneure AJ; Tytgat J Drug Test Anal; 2016 Jan; 8(1):136-40. PubMed ID: 26333168 [No Abstract] [Full Text] [Related]
29. Synthesis and characterization of 5-methoxy-2-methyl-N,N-dialkylated tryptamines. Brandt SD; Tearavarich R; Dempster N; Cozzi NV; Daley PF Drug Test Anal; 2012 Jan; 4(1):24-32. PubMed ID: 22287290 [TBL] [Abstract][Full Text] [Related]
30. 5-HT neuroendocrine responses during psychotropic drug treatment: an investigation of the effects of lithium. Cowen PJ; Cohen PR; McCance SL; Friston KJ J Neurosci Methods; 1990 Sep; 34(1-3):201-5. PubMed ID: 2259242 [TBL] [Abstract][Full Text] [Related]
32. Systematic analytical characterization of new psychoactive substances: A case study. Lobo Vicente J; Chassaigne H; Holland MV; Reniero F; Kolář K; Tirendi S; Vandecasteele I; Vinckier I; Guillou C Forensic Sci Int; 2016 Aug; 265():107-15. PubMed ID: 26874735 [TBL] [Abstract][Full Text] [Related]
33. Identification of five substituted phenethylamine derivatives 5-MAPDB, 5-AEDB, MDMA methylene homolog, 6-Br-MDMA, and 5-APB-NBOMe. Liu C; Jia W; Qian Z; Li T; Hua Z Drug Test Anal; 2017 Feb; 9(2):199-207. PubMed ID: 26856255 [TBL] [Abstract][Full Text] [Related]
34. Psychoactive substances in human breast milk: a review of analytical strategies for their investigation. Ramos Santos WJ; De Martinis BS Bioanalysis; 2020 Sep; 12(17):1263-1274. PubMed ID: 32893670 [TBL] [Abstract][Full Text] [Related]
35. Quantitative microlocation of lithium in the brain by a (n, alpha) nuclear reaction. Thellier M; Wissocq JC; Heurteaux C Nature; 1980 Jan; 283(5744):299-302. PubMed ID: 7352003 [No Abstract] [Full Text] [Related]
37. The Texture of Psychoactive Illicit Drugs in Iran: Adulteration with Lead and other Active Pharmaceutical Ingredients. Akhgari M; Moradi F; Ziarati P J Psychoactive Drugs; 2018; 50(5):451-459. PubMed ID: 30130472 [TBL] [Abstract][Full Text] [Related]
38. Psychoactive drugs on brain acetylcholine (Ach) levels in rats. Gupta SB Indian J Physiol Pharmacol; 1980; 24(1):71-2. PubMed ID: 7364465 [No Abstract] [Full Text] [Related]
39. Editorial on "New challenges and innovation in forensic toxicology: focus on the 'New Psychoactive Substances'" by Donata Favretto, Jennifer P. Pascali and Franco Tagliaro. Fanali S J Chromatogr A; 2013 Apr; 1287():83. PubMed ID: 23394944 [No Abstract] [Full Text] [Related]
40. In vivo imaging of the pharmacodynamics and pharmacokinetics of lithium. Kilts CD J Clin Psychiatry; 2000; 61 Suppl 9():41-6. PubMed ID: 10826660 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]